Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DYRK3 antisense RNA 1 (DYRK3-AS1)
- Target
- DYRK3-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
DYRK3 antisense RNA 1 (DYRK3-AS1) is a long non-coding antisense RNA transcribed from the opposite strand at the DYRK3 gene locus. Antisense RNAs are non-coding RNA molecules that are complementary to protein-coding (sense) mRNA transcripts and are known to regulate gene expression at transcriptional or post-transcriptional levels, often through processes like transcriptional interference, RNA stability modulation, or chromatin remodeling[2][4]. The exact biological function, disease roles, or potential as a therapeutic target for DYRK3-AS1 specifically is not well characterized in the available literature, but by analogy to other antisense RNAs, it may modulate the expression of the DYRK3 gene, possibly affecting cellular processes regulated by DYRK3 kinase activity. There is no evidence that DYRK3-AS1 is a direct therapeutic target, nor are there known disease roles, drug interactions, or biomarker uses for this molecule based on available information[4][2].
- Other names
- DYRK3-AS1
02
Biological functions
Regulation of gene expression (likely of DYRK3)Potential role in transcriptional interference or silencing
Beyond the preview
Go deeper on DYRK3 antisense RNA 1 (DYRK3-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DYRK3 antisense RNA 1 (DYRK3-AS1).